Nihal

May the trend 📈 be with you.

[Nihal @4nihal404]

#gngelectronics came to me as a Data centre proxy, but how is that what you are wondering.

Gng Electronics completed its 1 year of listing recently.

Here is a detailed analysis of how that is and what company had said i their latest #concall

https://t.co/iQUjUyHs0f

[Nihal @4nihal404]

#sudeeppharma going vertical 🚀crossing 930
#concall
- Due to LPG constraints the specialty segment had sub 50% utilization; Rev growth 19% yoy
- Mulling phase 1 battery plant capacity to double; commissioning by 2030
- EBITDA margins to sustain above 35%

[Nihal @4nihal404]

#SudeepPharma 180 days lock-in period over and get set 🚀.
#sudeep is moving from nutrition #suppliments to #bess
Covered #sudeepphrm 50 day's ago https://t.co/GzC7uCjpkQ

[Nihal @4nihal404]

@IshanTanna1 Shayad mera uncommon wali list main hoga 🥺

[Nihal @4nihal404]

@suryachaudhary1 I agree on that, they provide a data point; but if you blindly follow them without your own research then

[Nihal @4nihal404]

🚀 Q1 results profit surge for #TruAltBio!
Revenue: Up over 100% YoY 📈
PAT: Soared by over 11x 💰
OPM: Expanded 13% to 21% YoY
Net Margin: Jumped 1.6% to 9.4%
🎙️ Concall Today at 11:00 AM. Worth keeping a close eye on management commentary!

[Nihal @4nihal404]

#Ethenol producers seem to be in good books of the market, with rising crude prices and #aviation fule blending talks.
Covered #trualt india's #1 Ethenol producer 2 weeks ago.
https://t.co/J6nJw30u0s
#trualtbio #godavribio #saf

[Nihal @4nihal404]

Near ATH, result on next Tuesday.

[Nihal @4nihal404]

#sbiamc bought 2 Million shares of Sudeep Pharma last week, 10 days before the quarterly results on 4th Aug.

Find out more about the company on the video below.

[Nihal @4nihal404]

@suryachaudhary1 Transrail is something i really like, it had good cashflow last year, but the int business is what keeps me away

[Nihal @4nihal404]

@itsTarH @Manojeet_Das Breaking 20WEMA for the first time since listing, and 50% down in 30 days

[Nihal @4nihal404]

What are your thoughts on Senores prioritizing compliance and oral solids for faster commercialization?

#SenoresPharma #StockMarketIndia #PharmaSector #ConcallNotes #Investing #FinancialResults #IndianStockMarket

[Nihal @4nihal404]

🚀 Senores Pharmaceuticals | Q1 FY27 Concall Highlights & Key Takeaways
Senores Pharma presented a strong operational and strategic outlook during its Q1 FY27 concall. Here are the core metrics and key strategic shifts investors should track:

[Nihal @4nihal404]

🏭 Cash Flows & Macro De-risking
Cash Generation: Emerging markets business is cash-flow positive, generating ₹18 Cr in OCF.
Acknowledged potential US import tariffs on generics, but maintains a neutral position due to dual manufacturing footprints across both India and the USA.

[Nihal @4nihal404]

@IshanTanna1 Waiting for Milky Mist for a while, but dairy seems to be a tough nut to crack.